Results of AstraZeneca PLC Annual General Meeting

AstraZeneca PLC held its Annual General Meeting (AGM) on April 9, 2026, where all proposed resolutions were decided by poll vote. Resolutions 10-13 were passed as special resolutions, while others were ordinary resolutions. Key resolutions included receiving the company's accounts and reports, appointing KPMG LLP as auditor, authorizing directors to agree auditor remuneration, and re-electing several directors, all with high percentages of 'for' votes. The company also received approval for its remuneration report and to renew awards under its Performance Share Plan. Resolutions to authorize political donations and to allot shares, including disapplying pre-emption rights, were also passed. The company announced that Nazneen Rahman retired from the Board at the conclusion of the AGM and will receive pro-rata fees for April 2026. The total issued share capital as of April 7, 2026, was 1,550,988,781 ordinary shares.